Freshfields advised SERB Pharmaceuticals on Purchase of RSDL (Reactive Skin Decontamination Lotion) Kit from Emergent BioSolutions Inc. Mayer Brown advised SERB Pharmaceuticals and its majority shareholder,...
SERB Pharmaceuticals’ Acquisition of RSDL
Merz Therapeutics’ $185m Acquisition of Acorda Therapeutics
Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...